Affiner les résultats

Depressive symptoms and emotion regulation strategies in children with and without developmental language disorder : a longitudinal study

den Bedem, Neeltje P. ; Dockrell, Julie E. ; Alphen, Petra M. ; Rooij, Mark ; Samson, Andrea C. ; Harjunen, Elina L. ; Rieffe, Carolien

In: International Journal of Language & Communication Disorders, 2018, vol. 53, no. 6, p. 1110-1123

Background: Depressive symptoms are common in children with developmental language disorder (DLD). However, risk and protective factors contributing to these problems are currently underspecified. Aims: The current longitudinal study examined the role of emotion-regulation (ER) strategies in the severity of depressive symptoms in children with and without DLD, taking into account the severity...

Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy

Taniwaki, Masanori ; Radu, Maria ; Garcia-Garcia, Hector ; Heg, Dik ; Kelbæk, Henning ; Holmvang, Lene ; Moschovitis, Aris ; Noble, Stephane ; Pedrazzini, Giovanni ; Saunamäki, Kari ; Dijkstra, Jouke ; Landmesser, Ulf ; Wenaweser, Peter ; Meier, Bernhard ; Stefanini, Giulio ; Roffi, Marco ; Lüscher, Thomas ; Windecker, Stephan ; Räber, Lorenz

In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 5, p. 915-926

Cost-effectiveness of drug-eluting stents in elderly patients with coronary artery disease: the SENIOR trial

Bulsei, Julie ; Butel, Thibault ; Varenne, Olivier ; Cook, Stéphane ; Cuisset, Thomas ; Carrié, Didier ; Hovasse, Thomas ; Morice, Marie-Claude ; Sinnaeve, Peter R. ; Durand-Zaleski, Isabelle

In: Value in Health, 2019, vol. 22, no. 12, p. 1355–1361

Elderly patients receive bare metal stents instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT). The SENIOR trial compared outcomes between these 2 types of stents combined with a short duration of DAPT. A significant decrease in the number of patients with at least 1 major adverse cardiac and cerebrovascular event (MACCE) was noted in the DES...

Hypoxia enhances endothelial intercellular adhesion molecule 1 protein level through upregulation of arginase type II and mitochondrial oxidative stress

Liang, Xiujie ; Arullampalam, Prakash ; Yang, Zhihong ; Ming, Xiu-Fen

In: Frontiers in Physiology, 2019, vol. 10, p. -

Hypoxia plays a crucial role in the pathogenesis of cardiovascular diseases. Mitochondrial enzyme arginase type II (Arg-II) is reported to lead to endothelial dysfunction and enhance the expression of endothelial inflammatory adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). In this study, we investigate the role of Arg-II in...

Resolute zotarolimus‐eluting stent in ST‐elevation myocardial infarction (resolute‐STEMI): A prespecified prospective register from the DAPT‐STEMI trial

Postma, Warner ; Fabris, Enrico ; Ent, Martin Van der ; Hermanides, Rik ; Buszman, Pawel ; Birgelen, Clemens Von ; Cook, Stéphane ; Wedel, Hans ; Luca, Giuseppe De ; Delewi, Ronak ; Zijlstra, Felix ; Kedhi, Elvin

In: Catheterization and Cardiovascular Interventions, 2019, p. ccd.28376

To evaluate the safety and efficacy outcomes after primary percutaneous coronary intervention (pPCI) with second‐generation Resolute™ zotarolimus‐eluting stent (R‐ ZES) in patients enrolled in the DAPT‐STEMI Trial (NCT01459627).Background: R‐ ZES is one of the most used drug eluting stents worldwide. To date, the safety and efficacy data of this stent in setting of STEMI is...

Absorb bioresorbable scaffold versus xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis: rationale and design of the COMPARE ABSORB trial

Chang, Chun Chin ; Onuma, Yoshinobu ; Achenbach, Stephan ; Barbato, Emanuele ; Chevalier, Bernard ; Cook, Stéphane ; Dudek, Dariusz ; Escaned, Javier ; Gori, Tommaso ; Kočka, Viktor ; Tarantini, Giuseppe ; E.J.West, Nick ; Morice, Marie-Claude ; G.P.Tijssen, Jan ; Geuns, Robert-Janvan ; C.Smits, Pieter

In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582

Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...

Cardio- and cerebrovascular responses to the energy drink Red Bull in young adults: a randomized cross-over study

Grasser, Erik ; Yepuri, Gayathri ; Dulloo, Abdul ; Montani, Jean-Pierre

In: European Journal of Nutrition, 2014, vol. 53, no. 7, p. 1561-1571

Coronary Sinus Atresia With Persistent Left Superior Vena Cava: Unusual Clinical Presentation and Endovascular Management

Qanadli, Salah ; Rolf, Tanina ; Glauser, Frederic ; Delay, Dominique ; Beigelman-Aubry, Catherine ; Prêtre, René

In: CardioVascular and Interventional Radiology, 2014, vol. 37, no. 3, p. 825-828

A PET/CT-follow-up imaging study to differentiate takotsubo cardiomyopathy from acute myocardial infarction

Ghadri, Jelena ; Dougoud, Svetlana ; Maier, Willibald ; Kaufmann, Philipp ; Gaemperli, Oliver ; Prasad, Abhiram ; Lüscher, Thomas ; Templin, Christian

In: The International Journal of Cardiovascular Imaging, 2014, vol. 30, no. 1, p. 207-209

Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: 5-year outcomes of the randomized bioflow-ii trial

Lefèvre, Thierry ; Haude, Michael ; Neumann, Franz-Josef ; Stang, Karl ; Skurk, Carsten ; Slagboom, Ton ; Sabaté, Manel ; Goicolea, Javier ; Barragan, Paul ; Cook, Stéphane ; Macia, Jean-Christophe ; Windecker, Stephan

In: JACC: Cardiovascular Interventions, 2018, vol. 11, no. 10, p. 995–1002

ObjectivesThe authors aimed to compare long-term data of an ultrathin cobalt- chromium stent with passive silicon carbide coating and an active biodegradable polymer that releases sirolimus (O-SES) (Orsiro, BIOTRONIK, Bülach, Switzerland) with the durable polymer-based Xience Prime everolimus-eluting stent (X-EES) (Abbott Vascular, Santa Clara, California).BackgroundBiodegradable polymer...